Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.57 Million EUR | -80.95% |
| 2022 | 18.74 Million EUR | -44.02% |
| 2021 | 33.48 Million EUR | -47.8% |
| 2020 | 64.15 Million EUR | 157.88% |
| 2019 | 24.87 Million EUR | -5.67% |
| 2018 | 26.37 Million EUR | -6.22% |
| 2017 | 28.11 Million EUR | 3.3% |
| 2016 | 27.22 Million EUR | -7.78% |
| 2015 | 29.52 Million EUR | -4.72% |
| 2014 | 30.98 Million EUR | 5.54% |
| 2013 | 29.35 Million EUR | 8.5% |
| 2012 | 27.05 Million EUR | 15.1% |
| 2011 | 23.5 Million EUR | -9.69% |
| 2010 | 26.02 Million EUR | 11.12% |
| 2009 | 23.42 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -525 Thousand EUR | 0.0% |
| 2023 Q4 | -1.69 Million EUR | 0.0% |
| 2023 Q3 | -1.69 Million EUR | -236.32% |
| 2023 Q2 | 1.24 Million EUR | -64.25% |
| 2023 Q1 | 3.48 Million EUR | 194.11% |
| 2023 FY | 3.57 Million EUR | -80.95% |
| 2022 FY | 18.74 Million EUR | -44.02% |
| 2022 Q1 | 4.75 Million EUR | 327.45% |
| 2022 Q2 | 4.11 Million EUR | -13.52% |
| 2022 Q3 | 4.61 Million EUR | 12.27% |
| 2022 Q4 | -3.7 Million EUR | -180.15% |
| 2021 FY | 33.48 Million EUR | -47.8% |
| 2021 Q1 | 10.99 Million EUR | -66.66% |
| 2021 Q2 | 12.59 Million EUR | 14.47% |
| 2021 Q3 | 5.74 Million EUR | -54.37% |
| 2021 Q4 | -2.09 Million EUR | -136.4% |
| 2020 FY | 64.15 Million EUR | 157.88% |
| 2020 Q1 | 9.62 Million EUR | 121.72% |
| 2020 Q2 | 10.21 Million EUR | 6.12% |
| 2020 Q3 | 22.44 Million EUR | 119.76% |
| 2020 Q4 | 32.99 Million EUR | 46.98% |
| 2019 Q3 | 6.12 Million EUR | 99.33% |
| 2019 Q4 | 4.34 Million EUR | -29.16% |
| 2019 Q1 | 6.33 Million EUR | 0.0% |
| 2019 FY | 24.87 Million EUR | -5.67% |
| 2019 Q2 | 3.07 Million EUR | -51.49% |
| 2018 FY | 26.37 Million EUR | -6.22% |
| 2017 Q2 | 6.35 Million EUR | 0.0% |
| 2017 FY | 28.11 Million EUR | 3.3% |
| 2017 Q4 | 6.99 Million EUR | 0.0% |
| 2017 Q3 | 6.99 Million EUR | 10.16% |
| 2017 Q1 | 6.35 Million EUR | -14.45% |
| 2016 Q2 | 6.99 Million EUR | 0.0% |
| 2016 FY | 27.22 Million EUR | -7.78% |
| 2016 Q4 | 7.42 Million EUR | 0.0% |
| 2016 Q1 | 6.99 Million EUR | 5.56% |
| 2016 Q3 | 7.42 Million EUR | 6.24% |
| 2015 Q4 | 6.62 Million EUR | 0.0% |
| 2015 Q3 | 6.62 Million EUR | -7.32% |
| 2015 Q2 | 7.14 Million EUR | 0.0% |
| 2015 FY | 29.52 Million EUR | -4.72% |
| 2015 Q1 | 7.14 Million EUR | -4.91% |
| 2014 Q1 | 7.25 Million EUR | -4.47% |
| 2014 Q4 | 7.51 Million EUR | 0.0% |
| 2014 Q3 | 7.51 Million EUR | 3.66% |
| 2014 FY | 30.98 Million EUR | 5.54% |
| 2014 Q2 | 7.25 Million EUR | 0.0% |
| 2013 Q1 | 7.76 Million EUR | 7.95% |
| 2013 Q3 | 7.58 Million EUR | -2.32% |
| 2013 Q4 | 7.58 Million EUR | 0.0% |
| 2013 FY | 29.35 Million EUR | 8.5% |
| 2013 Q2 | 7.76 Million EUR | 0.0% |
| 2012 Q4 | 7.19 Million EUR | 0.0% |
| 2012 Q2 | 7.04 Million EUR | 0.0% |
| 2012 FY | 27.05 Million EUR | 15.1% |
| 2012 Q1 | 7.04 Million EUR | 2.3% |
| 2012 Q3 | 7.19 Million EUR | 2.24% |
| 2011 Q4 | 6.88 Million EUR | 0.0% |
| 2011 Q3 | 6.88 Million EUR | 0.0% |
| 2011 FY | 23.5 Million EUR | -9.69% |
| 2010 FY | 26.02 Million EUR | 11.12% |
| 2009 FY | 23.42 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | 397.631% |
| Bluelinea Société Anonyme | -3.84 Million EUR | 192.826% |
| Carmat SA | -30.97 Million EUR | 111.532% |
| Diagnostic Medical Systems S.A. | 15.84 Million EUR | 77.456% |
| Eurobio Scientific Société anonyme | 53.96 Million EUR | 93.382% |
| Ikonisys S.A. | 255.82 Thousand EUR | -1296.09% |
| Implanet S.A. | 3.13 Million EUR | -14.035% |
| Median Technologies SA | -2.55 Million EUR | 240.007% |
| SpineGuard SA | 3.37 Million EUR | -5.698% |
| Theraclion SA | -1.08 Million EUR | 430.584% |
| Euroapi S.A. | 164.6 Million EUR | 97.83% |
| Guerbet SA | 197.14 Million EUR | 98.188% |
| Ion Beam Applications SA | 134.44 Million EUR | 97.343% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 99.952% |
| Sequana Medical NV | 548.04 Thousand EUR | -551.689% |